Alzheimer's

Richard Kadri-Langford

New Alzheimer's drug Donanemab - 35% slowing of cognitive decline?

Alzheimer's Disease (AD) is a degenerative brain disease that affects millions of people worldwide, and until now, no cure has been...

Dan Daly

"Momentous" Alzheimer's breakthrough increases the need for improved screening and monitoring.

Momentous lecanemab Alzheimer's breakthrough increases the need for improved Alzheimer's screening and monitoring devices.

Richard Kadri-Langford

Introducing Type 3 Diabetes

You may be familiar with the condition known as diabetes. If you or someone you know has diabetes you will probably be aware of the major...

Richard Kadri-Langford

Drug-free treatments for Alzheimer’s

Although ongoing research is helping to further our understanding of Alzheimer’s, at present it has to be seen as a progressive disease....

Kim Rasmussen

What is the global cost of Alzheimer’s?

“If global dementia care were a country, it would be the 18th largest economy in the world.”[1] That quote from Alzheimer’s Disease...

Richard Kadri-Langford

Global Dementia Numbers Predicted to Triple

A recent report in The Lancet has predicted that, given the projected trends in population ageing and population growth, the number of...

Kim Rasmussen

Why are women disproportionately affected by Alzheimer’s?

Should we be more worried about our mothers and grandmothers being diagnosed with Alzheimer’s disease than our fathers and grandfathers?...

Monica Giudice

Why Alzheimer’s disease is a growing problem?

The world’s population is aging rapidly. So much so that, according to a United Nations’ publication, [1] the number of people aged 65 or...

Monica Giudice

Excitement as US approves first new Alzheimer's drug in 20 years

Exciting news broke yesterday: regulators in the United States approved the first new treatment for Alzheimer’s disease in 20 years. The...